The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 12, 2016

Filed:

Aug. 17, 2012
Applicants:

Kenji Kangawa, Osaka, JP;

Hiroshi Hosoda, Osaka, JP;

Takashi Nojiri, Osaka, JP;

Meinoshin Okumura, Osaka, JP;

Mayumi Furuya, Kobe, JP;

Inventors:

Kenji Kangawa, Osaka, JP;

Hiroshi Hosoda, Osaka, JP;

Takashi Nojiri, Osaka, JP;

Meinoshin Okumura, Osaka, JP;

Mayumi Furuya, Kobe, JP;

Assignees:

National Cerebral and Cardiovascular Center, Suita-shi, Osaka, JP;

Osaka University, Suita-shi, Osaka, JP;

Shionogi & Co., Ltd., Osaka-shi, Osaka, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/22 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 38/22 (2013.01); A61K 38/2242 (2013.01); A61K 45/06 (2013.01);
Abstract

Provided are a medicinal agent which is highly safe for use as the treatment of a malignant tumor and is capable of efficiently treating a malignant tumor, that is, a medicinal agent for treating a malignant tumor or for suppressing or preventing the exacerbation thereof, comprising at least one kind of natriuretic peptide receptor GC-A agonist and at least one kind of natriuretic peptide receptor GC-B agonist to be administered in combination; a therapeutic method comprising administering the agent; etc.


Find Patent Forward Citations

Loading…